Veera Health, a digital health platform for women, raised $3 million in a funding round co-led by Sequoia Capital India’s Surge and Global Founders Capital. The funding round also saw participation from Y Combinator, CloudNine Hospitals’ co-founder Rohit MA, and Tinder India Head Taru Kapoor. Angel investors, participating in the round, included Benjamin Bryant, Ethan Perlstein, Holly Liu, Utsav Somani and Walter Chen. Veera Health is also backed by global tech accelerator Y Combinator. The company’s first product is a digital therapeutics platform that helps women identify and navigate PCOS, with a comprehensive offering of medical care, nutrition therapy, lifestyle coaching and doctor support.
Post-Pandemic future; jobs in the pharma industry are evolving lankabusinessonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lankabusinessonline.com Daily Mail and Mail on Sunday newspapers.
“New Science” is Driving More Growth than Predicted Against a Changing Economic Environment, According to Accenture ReportNew Science is expected to deliver 81 percent of industry revenue growth between 2021 and 2026Biopharma companies should streamline treatment discovery, development and commercializat.
11 gennaio 2021 07:37
Fonte: Adnkronos
#ict
Appian brings low-code speed and automation power to help drive innovation in drug discovery and scientific research
MCLEAN, Va., Jan. 9, 2021 /PRNewswire/ Appian (NASDAQ: APPN) today announced that it has joined Accenture s INTIENT partner ecosystem as a core partner. The ecosystem is designed to help independent software vendors (ISVs) and life science companies integrate more effectively to accelerate drug discovery efforts and improve patient outcomes.
The INTIENT Network is an integral part of Accenture s INTIENT Platform that enables insights and collaboration across the life sciences enterprise to improve productivity, efficiency, and innovation in drug discovery. Accenture has partnered with Appian to integrate low-code development into the INTIENT platform.